BIOMAT Database Logo BIOMAT Database Logo

A potent, tissue-selective, synthetic inhibitor of HMG-CoA reductase. 1989

N Balasubramanian, and P J Brown, and J D Catt, and W T Han, and R A Parker, and S Y Sit, and J J Wright
Cardiovascular Division, Bristol Myers Co., Wallingford, Connecticut 06492.

UI MeSH Term Description Entries
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D011714 Pyrans Pyran
D011753 Pyrones Keto-pyrans.
D002070 Butadienes Four carbon unsaturated hydrocarbons containing two double bonds. Butadiene Derivative,Butadiene Derivatives,Derivative, Butadiene,Derivatives, Butadiene
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D019161 Hydroxymethylglutaryl-CoA Reductase Inhibitors Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. HMG-CoA Reductase Inhibitor,HMG-CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Reductase Inhibitor,Statin,Statins, HMG-CoA,Inhibitors, HMG-CoA Reductase,Inhibitors, Hydroxymethylglutaryl-CoA,Inhibitors, Hydroxymethylglutaryl-Coenzyme A,Statins,HMG CoA Reductase Inhibitor,HMG CoA Reductase Inhibitors,HMG-CoA Statins,Hydroxymethylglutaryl CoA Reductase Inhibitor,Hydroxymethylglutaryl CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Inhibitors,Hydroxymethylglutaryl-Coenzyme A Inhibitors,Inhibitors, HMG CoA Reductase,Inhibitors, Hydroxymethylglutaryl CoA,Inhibitors, Hydroxymethylglutaryl Coenzyme A,Inhibitors, Hydroxymethylglutaryl-CoA Reductase,Reductase Inhibitor, Hydroxymethylglutaryl-CoA,Reductase Inhibitors, HMG-CoA,Reductase Inhibitors, Hydroxymethylglutaryl-CoA,Statins, HMG CoA

Related Publications

N Balasubramanian, and P J Brown, and J D Catt, and W T Han, and R A Parker, and S Y Sit, and J J Wright
L-669,262, a potent HMG-CoA reductase inhibitor.
March 1991, The Journal of antibiotics,
N Balasubramanian, and P J Brown, and J D Catt, and W T Han, and R A Parker, and S Y Sit, and J J Wright
NK-104: a novel synthetic HMG-CoA reductase inhibitor.
November 2000, Expert opinion on investigational drugs,
N Balasubramanian, and P J Brown, and J D Catt, and W T Han, and R A Parker, and S Y Sit, and J J Wright
Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects.
February 1990, British journal of clinical pharmacology,
N Balasubramanian, and P J Brown, and J D Catt, and W T Han, and R A Parker, and S Y Sit, and J J Wright
Clinical rationale for rosuvastatin, a potent new HMG-CoA reductase inhibitor.
January 2001, International journal of clinical practice,
N Balasubramanian, and P J Brown, and J D Catt, and W T Han, and R A Parker, and S Y Sit, and J J Wright
Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase.
January 1991, European journal of clinical pharmacology,
N Balasubramanian, and P J Brown, and J D Catt, and W T Han, and R A Parker, and S Y Sit, and J J Wright
[HMG-CoA reductase inhibitor, pravastatin].
August 1993, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
N Balasubramanian, and P J Brown, and J D Catt, and W T Han, and R A Parker, and S Y Sit, and J J Wright
Pitavastatin: a new HMG-CoA reductase inhibitor.
March 2010, The Annals of pharmacotherapy,
N Balasubramanian, and P J Brown, and J D Catt, and W T Han, and R A Parker, and S Y Sit, and J J Wright
HMG-CoA reductase inhibitor-induced impotence.
February 1996, The Annals of pharmacotherapy,
N Balasubramanian, and P J Brown, and J D Catt, and W T Han, and R A Parker, and S Y Sit, and J J Wright
Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor.
November 1997, Atherosclerosis,
N Balasubramanian, and P J Brown, and J D Catt, and W T Han, and R A Parker, and S Y Sit, and J J Wright
Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor.
January 2003, Cardiovascular drug reviews,
Copied contents to your clipboard!